Literature DB >> 27488654

Loss of MPZL3 function causes seborrhoeic dermatitis-like phenotype in mice.

Tongyu C Wikramanayake1, Luis J Borda1, Robert S Kirsner1, Ying Wang2, Stephanie Duffort2, Andres Reyes-Capo2, Alexander Barsam2, Maite Urbieta2, Victor L Perez2.   

Abstract

Entities:  

Keywords:  alopecia; barrier; inflammation; sebaceous gland

Mesh：

Substances：

Year:  2016        PMID： 27488654      PMCID： PMC5292087          DOI： 10.1111/exd.13150

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


× No keyword cloud information.
  8 in total

1.  Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein.

Authors:  Ramon Y Birnbaum; Alex Zvulunov; Dafna Hallel-Halevy; Emanuella Cagnano; Gal Finer; Rivka Ofir; Dan Geiger; Eldad Silberstein; Yael Feferman; Ohad S Birk
Journal:  Nat Genet       Date:  2006-06-04       Impact factor: 38.330

2.  Mutation in Mpzl3, a novel [corrected] gene encoding a predicted [corrected] adhesion protein, in the rough coat (rc) mice with severe skin and hair abnormalities.

Authors:  Tongyu Cao; Peter Racz; Kornelia M Szauter; Gergely Groma; Garrett Y Nakamatsu; Benjamin Fogelgren; Eszter Pankotai; Qing-Ping He; Katalin Csiszar
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

3.  A novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease.

Authors:  Darryl A Oble; Elisabeth Collett; Mindy Hsieh; Malene Ambjørn; Jennie Law; Jan Dutz; Hung-Sia Teh
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

4.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

5.  Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis.

Authors:  Traci A Czyzyk; Jessica L Andrews; Tamer Coskun; Mark R Wade; Eric D Hawkins; John F Lockwood; Gabor Varga; Allison E Sahr; Yanyun Chen; Joseph T Brozinick; Kristine Kikly; Michael A Statnick
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-28       Impact factor: 4.310

6.  Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR.

Authors:  Aparna Bhaduri; Alexander Ungewickell; Lisa D Boxer; Vanessa Lopez-Pajares; Brian J Zarnegar; Paul A Khavari
Journal:  Dev Cell       Date:  2015-11-23       Impact factor: 12.270

7.  Loss of Mpzl3 function causes various skin abnormalities and greatly reduced adipose depots.

Authors:  Angel G Leiva; Anne L Chen; Priyadharshini Devarajan; Zhibin Chen; Shadi Damanpour; Jessica A Hall; Antonio C Bianco; Jie Li; Evangelos V Badiavas; Julia Zaias; Mariya Miteva; Paolo Romanelli; Keyvan Nouri; Tongyu Cao Wikramanayake
Journal:  J Invest Dermatol       Date:  2014-02-14       Impact factor: 8.551

8.  Seborrheic Dermatitis and Dandruff: A Comprehensive Review.

Authors:  Luis J Borda; Tongyu C Wikramanayake
Journal:  J Clin Investig Dermatol       Date:  2015-12-15
  8 in total
  3 in total

1.  Antisense oligonucleotide-mediated knockdown of Mpzl3 attenuates the negative metabolic effects of diet-induced obesity in mice.

Authors:  Beth L Worley; Thomas Auen; Amy C Arnold; Brett P Monia; Nadine Hempel; Traci A Czyzyk
Journal:  Physiol Rep       Date:  2021-05

2.  Met-HER3 crosstalk supports proliferation via MPZL3 in MET-amplified cancer cells.

Authors:  Yaakov E Stern; Abdulhameed Al-Ghabkari; Anie Monast; Benoit Fiset; Farzaneh Aboualizadeh; Zhong Yao; Igor Stagljar; Logan A Walsh; Stephanie Duhamel; Morag Park
Journal:  Cell Mol Life Sci       Date:  2022-03-05       Impact factor: 9.207

3.  A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer.

Authors:  Renhong Huang; Liangqiang Li; Zheng Wang; Kunwei Shen
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.